{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:46:49Z","timestamp":1790401609097,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s00432-020-03377-6","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T14:03:47Z","timestamp":1599141827000},"page":"871-879","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Multigene panel testing for hereditary breast and ovarian cancer in the province of Ontario"],"prefix":"10.1007","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3685-5679","authenticated-orcid":false,"given":"Jordan","family":"Lerner-Ellis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Mighton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conxi","family":"Lazaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Di Gioacchino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin C.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George S.","family":"Charames","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,3]]},"reference":[{"issue":"4","key":"3377_CR1","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1159\/000279623","volume":"13","author":"W Burke","year":"2010","unstructured":"Burke W, Laberge AM, Press N (2010) Debating clinical utility. Public Health Genomics 13(4):215\u2013223. https:\/\/doi.org\/10.1159\/000279623","journal-title":"Public Health Genomics"},{"issue":"10","key":"3377_CR2","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1002\/cncr.30498","volume":"123","author":"SS Buys","year":"2017","unstructured":"Buys SS, Sandbach JF, Gammon A, Patel G, Kidd J, Brown KL et al (2017) A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes. Cancer 123(10):1721\u20131730. https:\/\/doi.org\/10.1002\/cncr.30498","journal-title":"Cancer"},{"issue":"28","key":"3377_CR3","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.1200\/jco.2010.34.0778","volume":"29","author":"C Cybulski","year":"2011","unstructured":"Cybulski C, Wokolorczyk D, Jakubowska A, Huzarski T, Byrski T, Gronwald J et al (2011) Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer. J Clin Oncol 29(28):3747\u20133752. https:\/\/doi.org\/10.1200\/jco.2010.34.0778","journal-title":"J Clin Oncol"},{"issue":"9","key":"3377_CR4","doi-asserted-by":"publisher","first-page":"e025317","DOI":"10.1136\/bmjopen-2018-025317","volume":"8","author":"F Dossa","year":"2018","unstructured":"Dossa F, Cusimano MC, Sutradhar R, Metcalfe K, Little T, Lerner-Ellis J et al (2018) Real-world health services utilisation and outcomes after BRCA1 and BRCA2 testing in Ontario, Canada: the What Comes Next Cohort Study protocol. BMJ Open 8(9):e025317. https:\/\/doi.org\/10.1136\/bmjopen-2018-025317","journal-title":"BMJ Open"},{"issue":"10","key":"3377_CR5","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1002\/ijc.32304","volume":"145","author":"L Feliubadalo","year":"2019","unstructured":"Feliubadalo L, Lopez-Fernandez A, Pineda M, Diez O, Del Valle J, Gutierrez-Enriquez S et al (2019) Opportunistic testing of BRCA1, BRCA2 and mismatch repair genes improves the yield of phenotype driven hereditary cancer gene panels. Int J Cancer 145(10):2682\u20132691. https:\/\/doi.org\/10.1002\/ijc.32304","journal-title":"Int J Cancer"},{"issue":"3","key":"3377_CR6","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/cge.12647","volume":"89","author":"A Finch","year":"2016","unstructured":"Finch A, Wang M, Fine A, Atri L, Khalouei S, Pupavac M et al (2016) Genetic testing for BRCA1 and BRCA2 in the Province of Ontario. Clin Genet 89(3):304\u2013311. https:\/\/doi.org\/10.1111\/cge.12647","journal-title":"Clin Genet"},{"issue":"4","key":"3377_CR7","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.pathol.2017.03.002","volume":"49","author":"MG Keeney","year":"2017","unstructured":"Keeney MG, Couch FJ, Visscher DW, Lindor NM (2017) Non-BRCA familial breast cancer: review of reported pathology and molecular findings. Pathology 49(4):363\u2013370. https:\/\/doi.org\/10.1016\/j.pathol.2017.03.002","journal-title":"Pathology"},{"key":"3377_CR8","unstructured":"Kohlmann, W., & Gruber, S. B. (2018). Lynch Syndrome. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1211\/"},{"issue":"2","key":"3377_CR9","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41436-019-0633-8","volume":"22","author":"H LaDuca","year":"2020","unstructured":"LaDuca H, Polley EC, Yussuf A, Hoang L, Gutierrez S, Hart SN et al (2020) A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients. Genet Med 22(2):407\u2013415. https:\/\/doi.org\/10.1038\/s41436-019-0633-8","journal-title":"Genet Med"},{"key":"3377_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-018-0361-5","author":"K Lee","year":"2018","unstructured":"Lee K, Seifert BA, Shimelis H, Ghosh R, Crowley SB, Carter NJ et al (2018) Clinical validity assessment of genes frequently tested on hereditary breast and ovarian cancer susceptibility sequencing panels. Genet Med. https:\/\/doi.org\/10.1038\/s41436-018-0361-5","journal-title":"Genet Med"},{"issue":"11","key":"3377_CR11","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1586\/14737140.2015.1090879","volume":"15","author":"J Lerner-Ellis","year":"2015","unstructured":"Lerner-Ellis J, Khalouei S, Sopik V, Narod SA (2015) Genetic risk assessment and prevention: the role of genetic testing panels in breast cancer. Expert Rev Anticancer Ther 15(11):1315\u20131326. https:\/\/doi.org\/10.1586\/14737140.2015.1090879","journal-title":"Expert Rev Anticancer Ther"},{"issue":"2","key":"3377_CR12","doi-asserted-by":"publisher","first-page":"e293","DOI":"10.1016\/j.clcc.2018.01.001","volume":"17","author":"M Lorans","year":"2018","unstructured":"Lorans M, Dow E, Macrae F, Winship I, Buchanan D (2018) Update on hereditary colorectal cancer: improving the clinical utility of multigene panel testing. Clin Colorectal Cancer 17(2):e293\u2013e305","journal-title":"Clin Colorectal Cancer"},{"issue":"3","key":"3377_CR13","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/gim.2017.207","volume":"20","author":"S Macklin","year":"2018","unstructured":"Macklin S, Durand N, Atwal P, Hines S (2018) Observed frequency and challenges of variant reclassification in a hereditary cancer clinic. Genet Med 20(3):346\u2013350. https:\/\/doi.org\/10.1038\/gim.2017.207","journal-title":"Genet Med"},{"issue":"10","key":"3377_CR14","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1038\/s41436-019-0493-2","volume":"21","author":"C Mighton","year":"2019","unstructured":"Mighton C, Charames G, Wang M, Zakoor K, Wong A, Shickh S et al (2019) Variant classification changes over time in BRCA1 and BRCA2. Genet Med 21(10):2248\u20132254","journal-title":"Genet Med"},{"issue":"38","key":"3377_CR15","doi-asserted-by":"publisher","first-page":"6445","DOI":"10.1038\/sj.onc.1207714","volume":"23","author":"R Nagy","year":"2004","unstructured":"Nagy R, Sweet K, Eng C (2004) Highly penetrant hereditary cancer syndromes. Oncogene 23(38):6445\u20136470. https:\/\/doi.org\/10.1038\/sj.onc.1207714","journal-title":"Oncogene"},{"key":"3377_CR16","unstructured":"National Collaborating Centre for Cancer (2013) National Institute for Health and Clinical Excellence: Guidance. In: Familial Breast Cancer: Classification and Care of People at Risk of Familial Breast Cancer and Management of Breast Cancer and Related Risks in People with a Family History of Breast Cancer. Cardiff: National Collaborating Centre for Cancer (UK)"},{"key":"3377_CR17","unstructured":"National Comprehensive Cancer Network (2017) Genetic\/familial high-risk assessment: breast and ovarian (version 2.2017). In: National Comprehensive Cancer Network."},{"issue":"4","key":"3377_CR18","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.jmoldx.2019.03.001","volume":"21","author":"CL Neben","year":"2019","unstructured":"Neben CL, Zimmer AD, Stedden W, van den Akker J, O'Connor R, Chan RC et al (2019) Multi-gene panel testing of 23,179 individuals for hereditary cancer risk identifies pathogenic variant carriers missed by current genetic testing guidelines. J Mol Diagn 21(4):646\u2013657. https:\/\/doi.org\/10.1016\/j.jmoldx.2019.03.001","journal-title":"J Mol Diagn"},{"issue":"10","key":"3377_CR19","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1245\/s10434-017-5963-7","volume":"24","author":"E O'Leary","year":"2017","unstructured":"O'Leary E, Iacoboni D, Holle J, Michalski ST, Esplin ED, Yang S, Ouyang K (2017) Expanded gene panel use for women with breast cancer: identification and intervention beyond breast cancer risk. Ann Surg Oncol 24(10):3060\u20133066. https:\/\/doi.org\/10.1245\/s10434-017-5963-7","journal-title":"Ann Surg Oncol"},{"key":"3377_CR20","unstructured":"Petrucelli N, Daly M, Pal T (2016) BRCA1- and BRCA2-associated hereditary breast and ovarian cancer. GeneReviews\u00ae. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1247\/"},{"issue":"9","key":"3377_CR21","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1080\/14737140.2019.1659730","volume":"19","author":"C Piccinin","year":"2019","unstructured":"Piccinin C, Panchal S, Watkins N, Kim RH (2019) An update on genetic risk assessment and prevention: the role of genetic testing panels in breast cancer. Expert Rev Anticancer Ther 19(9):787\u2013801. https:\/\/doi.org\/10.1080\/14737140.2019.1659730","journal-title":"Expert Rev Anticancer Ther"},{"issue":"5","key":"3377_CR22","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"key":"3377_CR23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1146\/annurev-genom-091416-035305","volume":"18","author":"PD Shah","year":"2017","unstructured":"Shah PD, Nathanson KL (2017) Application of panel-based tests for inherited risk of cancer. Annu Rev Genomics Hum Genet 18:201\u2013227. https:\/\/doi.org\/10.1146\/annurev-genom-091416-035305","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"8","key":"3377_CR24","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/gim.2015.166","volume":"18","author":"LR Susswein","year":"2016","unstructured":"Susswein LR, Marshall ML, Nusbaum R, Vogel Postula KJ, Weissman SM, Yackowski L et al (2016) Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing. Genet Med 18(8):823\u2013832. https:\/\/doi.org\/10.1038\/gim.2015.166","journal-title":"Genet Med"},{"key":"3377_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-018-0063-z","author":"SA Turner","year":"2018","unstructured":"Turner SA, Rao SK, Morgan RH, Vnencak-Jones CL, Wiesner GL (2018) The impact of variant classification on the clinical management of hereditary cancer syndromes. Genet Med. https:\/\/doi.org\/10.1038\/s41436-018-0063-z","journal-title":"Genet Med"}],"updated-by":[{"DOI":"10.1007\/s00432-020-03399-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T00:00:00Z","timestamp":1600992000000}}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-020-03377-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-020-03377-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-020-03377-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T18:31:24Z","timestamp":1630693884000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-020-03377-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["3377"],"URL":"https:\/\/doi.org\/10.1007\/s00432-020-03377-6","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,3]]},"assertion":[{"value":"20 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00432-020-03399-0","URL":"https:\/\/doi.org\/10.1007\/s00432-020-03399-0","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was obtained from the Research Ethics Board (REB) of Mount Sinai Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All authors consent to publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}